Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
CC transcript
|
|
Fresh Tracks Therapeutics, Inc. (VICL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Sklawer Andrew D (President and CEO) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 20,833 shares
@ $0.9798, valued at
$20.4k
Exercised 55,000 restricted stock units
@ $0 |
|
| 10/04/2023 |
4
| McAvoy David R. (Gen Counsel, CCO, & Secretary) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,358 shares
@ $0.9798, valued at
$7.2k
Exercised 20,000 restricted stock units
@ $0 |
|
| 01/26/2023 |
4
| McAvoy David R. (Gen Counsel, CCO, & Secretary) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 01/26/2023 |
4
| Sklawer Andrew D (President) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Granted 55,000 restricted stock units
@ $0 |
|
| 01/26/2023 |
4
| MARCHIO ALBERT N II (CFO) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Granted 1,250 restricted stock units
@ $0 |
|
| 01/26/2023 |
4
| Chadha Deepak (Chief R&D Officer and COO) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Granted 35,000 restricted stock units
@ $0 |
|
| 05/17/2022 |
4
| HARDY REGINALD L (CHAIRMAN OF THE BOARD) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 65,000 options to buy
@ $0.1875, valued at
$12.2k
|
|
| 05/17/2022 |
4
| SAMANT VIJAY B (Director) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 65,000 options to buy
@ $0.1875, valued at
$12.2k
|
|
| 05/17/2022 |
4
| LYONS GARY A (Director) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 65,000 options to buy
@ $0.1875, valued at
$12.2k
|
|
| 05/17/2022 |
4
| VERU DENNISON T (Director) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 65,000 options to buy
@ $0.1875, valued at
$12.2k
|
|
| 05/09/2022 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 300,000 options to buy
@ $0.26, valued at
$78k
|
|
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| MARCHIO ALBERT N II (CFO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.26, valued at
$7.8k
|
|
| 05/09/2022 |
4
| Luchi Monica E. (Chief Medical Officer) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 325,000 options to buy
@ $0.26, valued at
$84.5k
|
|
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| HARDY REGINALD L (CHAIRMAN OF THE BOARD) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Paid exercise price by delivering 15,180 shares
@ $0.2289, valued at
$3.5k
|
|
| 09/03/2021 |
4
| Luchi Monica E. (Chief Medical Officer) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.7516, valued at
$300.6k
|
|
| 07/27/2021 |
4
| HARDY REGINALD L (CHAIRMAN OF THE BOARD) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Bought 100,000 shares
@ $0.6623, valued at
$66.2k
Bought 100,000 shares
@ $0.6742, valued at
$67.4k
|
|
| 07/27/2021 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Bought 18,124 shares
@ $0.6697, valued at
$12.1k
|
|
| 06/14/2021 |
4
| VERU DENNISON T (Director) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.9, valued at
$36k
|
|
| 06/14/2021 |
4
| HARDY REGINALD L (CHAIRMAN OF THE BOARD) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.9, valued at
$36k
|
|
| 06/14/2021 |
4
| Breton Jose (Chief Accounting Officer) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 85,000 options to buy
@ $0.9, valued at
$76.5k
|
|
| 06/14/2021 |
4
| MARCHIO ALBERT N II (CFO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.9, valued at
$18k
|
|
| 06/14/2021 |
4
| Sklawer Andrew D (COO and Secretary) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.9, valued at
$225k
|
|
| 06/14/2021 |
4
| Chadha Deepak (Chief Research & Dev. Officer) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.9, valued at
$225k
|
|
| 06/14/2021 |
4
| SAMANT VIJAY B (Director) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.9, valued at
$36k
|
|
| 06/14/2021 |
4
| Brown Robert Busard (CEO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 750,000 options to buy
@ $0.9, valued at
$675k
|
|
| 06/14/2021 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.9, valued at
$180k
|
|
| 06/14/2021 |
4
| LYONS GARY A (Director) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.9, valued at
$36k
|
|
| 05/19/2021 |
4
| Sklawer Andrew D (COO and Secretary) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Bought 15,375 shares
@ $0.8, valued at
$12.3k
|
|
| 05/19/2021 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Bought 18,622 shares
@ $0.8, valued at
$14.9k
Bought 7,980 shares
@ $0.8, valued at
$6.4k
|
|
| 05/19/2021 |
4
| Chadha Deepak (Chief Research & Dev. Officer) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Bought 2,700 shares
@ $0.8191, valued at
$2.2k
Bought 12,500 shares
@ $0.8302, valued at
$10.4k
|
|
|
|
|